1.
Phase 2 study of cemiplimab in patients with locally advanced basal cell carcinoma after hedgehog inhibitor therapy: Long-term follow-up. J of Skin [Internet]. 2023 Mar. 13 [cited 2025 Apr. 19];7(2):s178. Available from: https://skin.dermsquared.com/skin/article/view/2000